#1 Clinical Trials Search in Europe

L-PHENYLALANINE

L-Phenylalanine, an amino acid found in our diet, is being studied for its potential effects on gut health. A recent clinical trial examined how L-Phenylalanine supplements might influence the gut microbiome, particularly focusing on fungal populations. This amino acid can be converted by certain gut bacteria into phenylpropionic acid (PPA), a metabolite with potential antifungal properties. The study aimed to understand how supplementation affects PPA production and subsequently impacts the fungal communities living in our digestive system. This article explores the key aspects of this clinical trial and what it might mean for our understanding of dietary supplements and gut health.

Table of Contents

What is L-Phenylalanine?

L-Phenylalanine is an essential amino acid that our bodies cannot produce naturally, so we must obtain it through our diet or supplements. It’s classified as a dietary supplement and is being studied for its effects on gut health[1]. Essential amino acids are building blocks that our body needs but cannot make on its own.

This amino acid plays several important roles in the body, including helping to produce proteins and certain brain chemicals. In recent research, scientists have become particularly interested in how L-Phenylalanine might affect the balance of microorganisms in our digestive system[1].

How L-Phenylalanine Works in the Body

When consumed, L-Phenylalanine can be metabolized by certain bacteria in our gut, particularly a bacterium called Clostridium sporogenes. This bacterium transforms L-Phenylalanine into a compound called phenylpropionic acid (PPA)[1]. Phenylpropionic acid is a metabolite, which is simply a substance produced during metabolism or digestion.

This conversion process is important because PPA appears to have unique properties that may influence the balance of other microorganisms in our digestive system. Understanding this pathway is crucial for researchers exploring how dietary supplements might be used to promote gut health[1].

Effects on Gut Health and Microbiome

Our digestive tract contains a complex community of microorganisms known as the gut microbiome. This includes not just bacteria, but also fungi (called the mycobiota) and other microorganisms. The composition of these microbial communities can significantly impact our health[1].

Research suggests that the metabolites produced by different microbiota (including PPA) may selectively suppress or stimulate the growth of certain components of the gut microbiome. This means that by influencing the production of certain metabolites, we might be able to affect the balance of microorganisms in our gut[1].

Scientists are specifically investigating how L-Phenylalanine supplementation might change the levels of PPA in the gut and, consequently, how this might affect the populations of fungi living there[1].

Potential Antifungal Properties

One of the most intriguing aspects of PPA (the metabolite produced from L-Phenylalanine) is its potential antifungal activity. Multiple studies have observed that PPA may have antimicrobial and antifungal effects[1].

Laboratory research has shown that PPA may have activity against Candida albicans, a type of fungus that commonly lives in the human gut. While Candida is normally present without causing problems, under certain conditions it can overgrow and potentially lead to health issues[1].

Researchers are interested in whether increasing PPA levels through L-Phenylalanine supplementation might help maintain a healthy balance of fungal populations in the gut, particularly by keeping Candida levels in check[1].

Dosage Information

In current research studies, participants typically receive L-Phenylalanine as a vegetable capsule supplement. The dosage being studied is 500 mg capsules, with a regimen of two capsules (1000 mg total) in the morning and one capsule (500 mg) in the evening, for a daily total of 1500 mg[1].

This supplementation is typically continued for 14 days in research settings, though some studies follow participants for longer periods (up to 28 days) to assess both immediate and lasting effects[1].

It’s important to note that this dosage is specifically for research purposes, and anyone considering L-Phenylalanine supplementation should consult with a healthcare provider first, as individual needs and conditions vary.

Current Research Status

L-Phenylalanine is currently being studied in pilot clinical trials to better understand its effects on gut health. Researchers are specifically looking at several key outcomes[1]:

  • Changes in phenylpropionic acid levels – Scientists measure PPA levels in stool samples before and after L-Phenylalanine supplementation to see if the supplement successfully increases this potentially beneficial metabolite[1].
  • Changes in fungal populations – Using advanced sequencing techniques, researchers analyze how the populations of different fungi in the gut (especially Candida) change in response to L-Phenylalanine supplementation[1].
  • Immune system responses – Studies also examine how T cells (a type of immune cell) that react to fungal antigens might change during the supplementation period, providing insights into how the immune system interacts with gut fungi[1].

These studies represent early-stage research into potential new applications of L-Phenylalanine. While preliminary findings are promising, more extensive research is needed before specific health recommendations can be made[1].

Study Feature Details
Study Title Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study
Supplement Used L-Phenylalanine 500 mg vegetable capsules
Dosage Regimen 2 capsules (1000 mg) in the morning, 1 capsule (500 mg) in the evening, for 14 days
Primary Outcomes Measured 1. Changes in phenylpropionic acid (PPA) levels in stool
2. Changes in fungal populations (especially Candida) in stool
3. Changes in T cell reactivity to fungal antigens in blood
Measurement Timepoints Baseline, Week 2 (Day 14), Week 4 (Day 28)
Mechanism of Interest Conversion of L-Phenylalanine to PPA by gut bacteria (Clostridium sporogenes), and PPA’s subsequent effect on fungal populations
Potential Benefit Better understanding of how dietary supplements might influence gut fungal balance, potentially improving gut health

FAQ

  • What is L-Phenylalanine and why is it being studied? L-Phenylalanine is an amino acid naturally found in our diet. It's being studied because certain gut bacteria (specifically Clostridium sporogenes) can convert it into phenylpropionic acid (PPA), which has shown antifungal properties. Researchers want to understand if supplementing with L-Phenylalanine can increase PPA production and subsequently affect fungal populations in our gut, particularly organisms like Candida.
  • How was the L-Phenylalanine supplement administered in the clinical trial? In the clinical trial, participants received L-Phenylalanine 500 mg vegetable capsules. They were instructed to take two 500 mg capsules in the morning and one 500 mg capsule in the evening daily for a period of 14 days, totaling 1500 mg per day.
  • What measurements were taken during the study? The study measured three main outcomes: 1) Changes in phenylpropionic acid (PPA) levels in stool samples, 2) Changes in fungal populations (particularly Candida) in stool samples, and 3) Changes in the number of T cells (immune cells) that react to fungal antigens in blood samples. These measurements were taken at baseline, after 2 weeks (Day 14), and after 4 weeks (Day 28).
  • Why is the gut microbiome important for health? The gut microbiome, which includes bacteria and fungi living in our digestive system, plays a crucial role in our overall health. It influences digestion, immune function, and even mental health. The metabolites produced by these microbes can affect our body's pathophysiological responses. This study specifically focuses on how dietary supplements might alter the balance of fungal populations (mycobiota) in the gut, which could have implications for gut health.
  • What might be the potential benefits of altering gut fungal populations? Altering gut fungal populations, particularly reducing harmful fungi like certain Candida species, might help improve gut health and immune function. Overgrowth of certain fungi has been associated with various health issues. By understanding how L-Phenylalanine supplementation affects PPA production and fungal populations, researchers might identify new dietary approaches to maintain a healthy balance of microorganisms in the gut.

Ongoing Clinical Trials on L-PHENYLALANINE

  • Study on the Impact of Acetylcysteine and Drug Combination on Kidney Function in Living Donor Kidney Transplant Patients

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • L-Phenylalanine: An essential amino acid found in many foods that the body uses to make proteins. In this study, it's being investigated as a dietary supplement that can be converted by gut bacteria into compounds with potential antifungal properties.
  • Phenylpropionic acid (PPA): A metabolite produced when certain gut bacteria (specifically Clostridium sporogenes) break down the amino acid L-phenylalanine. It has been observed to have antimicrobial and antifungal effects.
  • Gut microbiome: The community of microorganisms, including bacteria, fungi, viruses, and other microbes, that live in the digestive tract. These microorganisms play important roles in digestion, immune function, and overall health.
  • Mycobiota: The fungal component of the microbiome. This refers specifically to the fungi species that live in the human gut or other body sites.
  • Candida albicans: A type of yeast (fungus) that normally lives in small amounts in the gut. Under certain conditions, it can overgrow and cause infections. This study examines how PPA might affect Candida levels in the gut.
  • Metabolite: A substance produced during metabolism (the chemical processes that occur within a living organism). In this context, PPA is a metabolite produced when bacteria break down L-phenylalanine.
  • Clostridium sporogenes: A species of bacteria found in the human gut that can metabolize L-phenylalanine to produce phenylpropionic acid (PPA).
  • T cells: A type of white blood cell that is a key part of the immune system. In this study, researchers measured how T cells react to fungal antigens before and after L-phenylalanine supplementation.
  • ELISA: Enzyme-Linked Immunosorbent Assay, a laboratory technique used to detect and measure antibodies or antigens in a sample. In this study, ELISA was used to help measure T cell reactivity to fungal antigens.
  • In vitro restimulation assays: Laboratory tests where cells are exposed to specific substances to measure their response. In this study, these assays were used to measure how T cells respond to fungal antigens.
  • Mass spectrometry: A laboratory technique used to identify and measure the amount of different molecules in a sample. In this study, it was used to measure PPA levels in stool samples.
  • Microbiota sequencing: A technique that identifies the genetic material of microorganisms in a sample, allowing researchers to determine which microbes are present and in what amounts. This was used to measure fungal populations in stool samples.

References

  1. https://clinicaltrials.gov/study/NCT06433310